Takashi Ishida

Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

Takashi Ishida, Tatsuro Joh, Naokuni Uike et al. · Journal of Clinical Oncology · 2012 · 649 citations · Full text

Medicine, Oncology, Pharmacology +17

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Michinori Ogura, Takashi Ishida, Kiyohiko Hatake et al. · Journal of Clinical Oncology · 2014 · 361 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.

Takashi Ishida, Atae Utsunomiya, Shinsuke Iida et al. · PubMed · 2003 · 354 citations

Medicine, Hematology, Oncology +14

Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma

Kazuhito Yamamoto, Atae Utsunomiya, Kensei Tobinai et al. · Journal of Clinical Oncology · 2010 · 351 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Specific Recruitment of CC Chemokine Receptor 4–Positive Regulatory T Cells in Hodgkin Lymphoma Fosters Immune Privilege

Takashi Ishida, Toshihiko Ishii, Atsushi Inagaki et al. · Cancer Research · 2006 · 289 citations · Full text

Life Sciences, Immunology, Oncology +17